Hyaluronidase activity in gynaecological cancer tissues with different metastatic forms

被引:0
作者
K Tamakoshi
F Kikkawa
O Maeda
N Suganuma
S Yamagata
T Yamagata
Y Tomoda
机构
[1] Nagoya University School of Medicine,Department of Obstetrics and Gynecology
来源
British Journal of Cancer | 1997年 / 75卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
We investigated hyaluronidase activity in gynaecological normal and malignant tissues. Hyaluronidase activity in culture medium of tissue specimens was detected by hyaluronic acid zymography and quantified by densitometry. Hyaluronidase activity was shown as one dominant band (molecular weight 65 kDa) at pH 3.5. Hyaluronidase activity was significantly higher in normal ovary (P < 0.05) and normal endometrium (P< 0.05) than in normal cervix. One dominant 65-kDa hyaluronidase was expressed in 100% (14 out of 14) of ovarian cancer tissues and in 91% (10 out of 11) of endometrial cancer tissues. However, hyaluronidase activity was not observed in cervical cancer tissues. Hyaluronidase activity was significantly higher in ovarian (P < 0.001) and endometrial (P < 0.01) cancer tissues than in cervical cancer tissue and was significantly higher in ovarian cancer tissue than in endometrial cancer tissue (P < 0.05). These facts suggest that the cancer cells make use of the original characteristic of the organ to invade and metastasize. Moreover, these results reflect the difference in metastatic forms and are suggestive of a strong relationship between hyaluronidase activity and invasion and metastasis of ovarian and endometrial cancers compared with cervical cancer.
引用
收藏
页码:1807 / 1811
页数:4
相关论文
共 50 条
[31]   Paclitaxel - An update of its use in the treatment of metastatic breast cancer and ovarian and other gynaecological cancers [J].
Wiseman, LR ;
Spencer, CM .
DRUGS & AGING, 1998, 12 (04) :305-334
[32]   Targeting Hyaluronidase for Cancer Therapy: Antitumor Activity of Sulfated Hyaluronic Acid in Prostate Cancer Cells [J].
Benitez, Anaid ;
Yates, Travis J. ;
Lopez, Luis E. ;
Cerwinka, Wolfgang H. ;
Bakkar, Ashraf ;
Lokeshwar, Vinata B. .
CANCER RESEARCH, 2011, 71 (12) :4085-4095
[33]   CHARACTERIZATION OF EXTRACELLULAR MATRIX-DEGRADING PROTEINASE AND ITS INHIBITOR IN GYNECOLOGIC CANCER TISSUES WITH CLINICALLY DIFFERENT METASTATIC FORM [J].
TAMAKOSHI, K ;
KIKKAWA, F ;
NAWA, A ;
ISHIKAWA, H ;
MIZUNO, K ;
TAMAKOSHI, A ;
YAMAGATA, S ;
SUGANUMA, N ;
TOMODA, Y .
CANCER, 1995, 76 (12) :2565-2571
[34]   [6]-gingerol as a Cancer Chemopreventive Agent: A Review of Its Activity on Different Steps of the Metastatic Process [J].
Poltronieri, Juliana ;
Becceneri, Amanda B. ;
Fuzer, Angelina M. ;
Cesar C. Filho, Julio ;
Martin, Ana Carolina B. M. ;
Vieira, Paulo Cezar ;
Pouliot, Normand ;
Cominetti, Marcia R. .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2014, 14 (04) :313-321
[35]   INDEXES OF HEMOSTASIS IN CANCER AND DIFFERENT FORMS OF JAUNDICE [J].
BOYAJIYAN, KP .
VOPROSY ONKOLOGII, 1985, 31 (05) :55-59
[36]   Treg cells in different forms of uterine cancer [J].
Hou, Fei ;
Ma, Daoxin ;
Cui, Baoxia .
CLINICA CHIMICA ACTA, 2013, 415 :337-340
[37]   First-in-human dose-escalation study of VCN-01, a selective oncolytic adenovirus with hyaluronidase activity in patients with advanced or metastatic cancer [J].
Hidalgo, M. ;
Gil, M. ;
Garcia-Carbonero, R. ;
Alvarez, R. ;
Laquente, B. ;
Moreno, R. ;
De Martino, A. ;
Alemany, R. ;
Capella, G. ;
Blasi, E. ;
Viaplana, I. ;
Cascallo, M. ;
Salazar, R. .
EUROPEAN JOURNAL OF CANCER, 2016, 69 :S99-S100
[38]   STUDY OF AHAS ACTIVITY PATTERN IN DIFFERENT SUNFLOWER TISSUES [J].
Ochogavia, A. ;
Breccia, G. ;
Vega, T. ;
Felitti, S. ;
Picardi, L. ;
Nestares, G. .
BIOCELL, 2013, 37 (03) :A156-A156
[39]   Mercaptopyruvate sulphurtransferase activity in different tissues of pigeons and chickens [J].
Tayefi-Nasrabadi, Hossein ;
Rahmani, Reza .
CLINICAL BIOCHEMISTRY, 2011, 44 (13) :S93-S93
[40]   NUCLEOSIDE PHOSPHOTRANSFERASE ACTIVITY IN TISSUES OF DIFFERENT ANIMAL SPECIES [J].
VENTO, R ;
TESORIERE, G ;
TESORIERE, L ;
CALVARUSO, G ;
TAIBI, G .
IRCS MEDICAL SCIENCE-BIOCHEMISTRY, 1981, 9 (09) :800-801